Drug Distribution Review Flashcards

(38 cards)

1
Q

What are the key components of passive diffusion?

A
  • Going down the concentration gradient (high to low)
  • Not saturated
  • Most common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two types of carrier mediated transport?

A
  • Facilitated diffusion
  • Active Transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe paracellular transport.

A

Paracellular transport is the movement of substances between adjacent cells, rather than through them. This process occurs across tight junctions that connect epithelial or endothelial cells and is primarily passive.
* Transport of the blood between tissues/cells
* For hydrophillic small molecules (uncharged)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does transcellular differ from paracellular transport?

A

Transcellular- through the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the key components of facilitated diffusion?

A
  • Not ATP dependent
  • Down concentration gradient
  • Via carriers
  • Saturatable- only so many carriers for the drug conc.
  • Ex. organic anion transporting polypeptides (OATP).–> Pravastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the key components of active transport?

A
  • Against conc. gradient
  • Via transporter
  • Uses ATP
  • Saturatable- only so many carriers for the drug conc.
  • Ex. P-glycoprotein–> Vincristine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is carrier-mediated transport saturated?

A

When there is a high drug concentration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What factors determine diffusion?

A
  • Molecular size
  • Lipophilicity
  • Charge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does molecular size impact diffusion?

A
  • Poor permeability for large molecules.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does lipophilicity impact diffusion?

A
  • poor permeability for hydrophilic molecules.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is LogP?

A
  • An indicator of compound lipophilicity
  • The higher the LogP value, the more lipophilic or hydrophobic the molecules are.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does charge impact diffusion?

A
  • There is poor permeability for charged molecules.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does ionized or unionized impact the diffusion?

A

Ionized compounds show poorer permeation through membrane
compared to un-ionized compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the rate limiting factor for distribution for small, lipophilic molecules?

A

The rate limiting step for drug distribution is the amount of blood carrying the drugs away. More blood=more distribution?

Perfusion-rate limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the rate limiting factor for distribution for small, hydrophilic molecules?

A

Rate-limiting step for drug distribution is the slow rate of drug passing the cell membrane.

Permeability-rate limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Given the following information, would the brain or muscle show faster propofol distribution?

Propofol
* General anesthesia-inducing agent
* Non-polar lipophilic compound (LogP=3.79)
* Distribution is PERFUSION-rate limited.

Brain
* Perfusion rate: 0.5 mg/min/g tissue

Muscle
* Perfusion rate: 0.025 ml/min/g tissue

A

The brain has a much higher perfusion rate than muscle (20 times higher). Therefore, propofol will distribute faster into the brain compared to muscle.

Simple: The higher the perfusion rate, the faster the drug is recieved in the tissue.

17
Q

What are the major drug-binding plasma proteins?

A
  • Albumin
  • alpha1-acid glycoprotein
  • Lipoproteins
18
Q

What are the characteristics of the binding-protein albumin?

A
  • The most abundant plasma protein (50% of human plasma proteins)
  • Produced in the liver
  • Binds free fatty acids, hormones, and weakly acidic (anionic) drugs.
  • Main fxn is to maintain the oncotic pressure of blood.
  • Serum levels are decreased in liver and kidney diseases.
19
Q

What are the characteristics of the binding-protein α1-Acid glycoprotein (AAG)?

A
  • Known as orosomucoid
  • Produced in the liver
  • Binds primarily weakly basic (cationic) drugs such as tertiary and quaternary amines
  • Serum levels increase during acute phase reaction (inflammation and burns)
  • Serum levels are decreased in liver and kidney diseases.
20
Q

What are the characteristics of the binding-protein called lipoproteins?

A
  • Lipophyllic protein and/or a complex of proteins and lipids.
  • Includes HDL and LDL
  • Binds hydrophobic drugs
  • Altered in some disease states, including heart disease.
21
Q

What are the five components of the free drug hypothesis?

A
  • Only free (unbound) drug exits capillaries to reach extravascular sites of action.
  • Only free (unbound) drug crosses cell membrane via diffusion.
  • Only free (unbound) drug binds to transporters
  • Only free (unbound) drugs cross the cell membrane and are eliminated.
  • Generally, the more lipophilic a compound is, the better its albumin binding is.

Ex. Liraglutide is more lipophilic than Exenatide, so it has a greater binding to albumin, and a much longer half-life.

22
Q

Is the plasma protein binding of drugs irreversible?

A

No; It is reversible.

23
Q

At equilibrium, how much of the free drug is on the both sides of the membrane?

A

The same on both sides

24
Q

Where do we measure drug concentration in the blood?

25
What is blood plasma?
* The liquid component of the blood, in which the blood cells are suspended (yellow colored). * Plasma make up about 55% of the total blood volume.
26
What proteins does plasma contain?
Fibrinogen, globulins, and albumin
27
How is blood serum different than blood plasma?
* Serum: the liquid portion of the blood AFTER clotting * Plasma: the liquid portion of the blood BEFORE clotting
28
What is serum?
The supernatuant fluid of the blood produced after the blood clotting occurs at the bottom of the tube.
29
Are there any clotting factors in serum?
NO! The serum is devoid of blood cells, fibrin, and clotting factors. This is because the factors were already used in the clotting. However, serum contains plasma proteins like albumin still.
30
How do we estimate fu through ultrafiltration?
The fraction unbound (fu) of a drug in plasma or serum can be estimated using ultrafiltration, which separates free (unbound) drug from protein-bound drug based on size exclusion.
31
What does C stand for?
Total drug concentration * Measure drug concentration after sample processing to etract both protein-bond and free drug molecules.
32
What does Cu stand for?
Free (unbound)drug concentration * Measure drug concentration after sample processing to exlude protein-bound drug molecules.
33
Fu= | In terms of concentration
Fu= Cu/C
34
What equation do we use to calculate the total volume of distribution (V(C)) for a drug?
V(C) = Vp(C) + VTW(CTW) * Vp(C)- the volume of plasma where the drug is initally distributed after administration * VTW(CTW)- The drug distributed into tissue water. * Overall, this equation means theat the total volume of distribition is the sum of the plasma volume and the tissue water volume influenced by the drug concentration.
35
fut=
fut= Cut/Ctw | In terms of concentration
36
# What does changing the variables below do to the volume (d)? V= Vp + VTW(Fu/Fut)
* The volume of distribution increases when Fu is increased * The volume of distribution decreases when Fut is increased.
37
How would decreased plasma protein binding impact the concentration of free drug in the blood?
* The concentration of free drug increases in the blood with less plasma binding. * This results in larger volume of distribution.
38
What does significant drug tissue protein binding cause?
* Lower free drug concentration in tissue * Larger volume of distribution.